{{slotProps.result.Title}} {{slotProps.result.Title}} {{slotProps.result.Title}} {{slotProps.result.Title}}

Tim Powell

Partner

Tim Powell, a London-based intellectual property (IP) and life sciences lawyer, represents clients in high-stakes litigation across UK and European courts. He advocates in the UK and European patent offices, the English High Court, Court of Appeal, Supreme Court, and the European Court of Justice. Tim is also an arbitrator on the World International Property Organization Arbitration and Mediation Centre's list of neutrals. His technical background and biotech and medical technologies industry knowledge have allowed him to represent clients in complex, multijurisdictional, and cross-border IP disputes and patent litigation.

"
A tenacious and highly effective litigator who you do not want on the other side of a case
The Legal 500
"
"
Truly outstanding in terms of both legal skill and acumen as well as technical ability
The Legal 500
"
"
Tim Powell is hugely respected for his patent litigation and advocacy practice.
Chambers
"
"
Tim Powell’s vast experience means that his approach is spot on. He is the person to have on the team when something unexpected happens.
Chambers
"
"
He is instrumental in developing and executing UK and EU strategies while keeping in mind clients’ ultimate business goals.
IAM Patents 1000
"
"
Excellent coordination of cross-border patent cases for pharma clients
Juve
"
"
An excellent strategist in patent disputes (competitor)
Juve
"
"
Tim is a great adviser in strategy, ensuring everything is moving in the right direction. It's a great experience working with him.
Chambers
"

Tim advises on critical IP issues, including supplementary protection certificates, orphan designations, and regulatory exclusivities for clients in life sciences and biotech seeking to remain competitive in European and UK-regulated markets.

He has managed bet-the-company litigation and complex cross-border licensing deals, leveraging his experience to protect trade secrets where patents may not apply. Tim also led one of the first reverse-payment settlement cases in Europe. He frequently advises on the antitrust implications of IP licensing, including fair, reasonable, and non-discriminatory (FRAND) terms.

Companies seek out Tim for his deep life sciences and biotech patent litigation, regulatory compliance, and cross-border strategy knowledge as IP laws evolve in the United Kingdom and European Union. His experience with complex, multijurisdictional disputes, combined with his strategic insights on leveraging regulatory exclusivities and managing antitrust risks, makes him an invaluable asset for clients seeking to safeguard innovation and optimize competitive advantage.

  • Represented a leading manufacturer of generic pharmaceuticals in its long-running litigation concerning a well-known drug; plaintiff alleged that the client infringed its patent for new use by marketing a “skinny label” product aimed at the off-patent, non-pain market; Supreme Court held plaintiff’s patent to be invalid
  • University of Bristol, England, post-graduate diploma, IP law
  • University of Cambridge, Sidney Sussex College, M.A., natural sciences
  • England & Wales

Listed, World IP Review, IP Leader (2024)

Listed, Managing IP, Patent Star (2024)

Listed, IAM Patent 1000: The World’s Leading Patent Professionals, UK Patent Litigation (Gold Tier) (2024)

Listed, Who’s Who Legal Patents and Life Sciences, Global Elite Thought Leader, Life Sciences – Patent Litigation (2024)

Listed, Legal 500, Hall of Fame, London, TMT (Technology, Media and Telecoms): Intellectual Property: Patents (Contentious and Non-Contentious) (2024)

Listed, Legal 500, Leading Individual, London, Industry Focus: Life Sciences and Healthcare (2024)

Listed, IAM Patent 1000: The World’s Leading Patent Professionals, Global Leader (2021, 2023)

Named, LMG Life Sciences, IP Lawyer of the Year: Medical devices, European Life Sciences Awards (2021–2022)

Member, European Patent Lawyers Association

Member, International Association for the Protection of Intellectual Property